How MedTech Is Using Breath Analysis for Early Disease Detection

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Unfollow podcast failed

How MedTech Is Using Breath Analysis for Early Disease Detection

Listen for free

View show details

Lucas and Luna explore the emerging field of breath-based diagnostics, focusing on how companies like Owlstone Medical are developing portable 'breathalyzers' that detect volatile organic compounds linked to lung cancer, asthma, and even infectious diseases. They discuss how this non-invasive technology could transform screening in primary care, the regulatory hurdles it faces, and the specific biomarkers being validated in clinical trials as of mid-2026. A concrete look at a technology that promises cheaper, faster, and more comfortable diagnosis. #BreathAnalysis #MedTech #Diagnostics #OwlstoneMedical #VolatileOrganicCompounds #LungCancerScreening #NonInvasiveDiagnosis #DigitalHealth #HealthTech #Biomarkers #PrimaryCare #ClinicalTrials #RegulatoryHurdles #FDA #PointOfCare #EarlyDetection #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

No reviews yet